Literature DB >> 27661647

Practice Bulletin No. 172 Summary: Premature Rupture of Membranes.

.   

Abstract

Preterm delivery occurs in approximately 12% of all births in the United States and is a major factor that contributes to perinatal morbidity and mortality (1, 2). Preterm premature rupture of membranes (PROM) complicates approximately 3% of all pregnancies in the United States (3). The optimal approach to clinical assessment and treatment of women with term and preterm PROM remains controversial. Management hinges on knowledge of gestational age and evaluation of the relative risks of delivery versus the risks of expectant management (eg, infection, abruptio placentae, and umbilical cord accident). The purpose of this document is to review the current understanding of this condition and to provide management guidelines that have been validated by appropriately conducted outcome-based research when available. Additional guidelines on the basis of consensus and expert opinion also are presented.

Entities:  

Mesh:

Year:  2016        PMID: 27661647     DOI: 10.1097/AOG.0000000000001703

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  PURLs: Deliver or wait with late preterm membrane rupture?

Authors:  Keri Bergeson; Shailendra Prasad
Journal:  J Fam Pract       Date:  2016-11       Impact factor: 0.493

2.  Epidemiological profile of patients with preterm premature rupture of membranes at a tertiary hospital in São Paulo, Brazil.

Authors:  Marco Aurélio Knippel Galletta; Roberto Eduardo Bittar; Isabela Agra; Eliane Cerqueira Leite Guerra; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib
Journal:  Clinics (Sao Paulo)       Date:  2019-10-21       Impact factor: 2.365

3.  Potential Serum Biomarkers Associated with Premature Rupture of Fetal Membranes in the First Trimester.

Authors:  Zhuoling An; Rui Zhao; Feifei Han; Yuan Sun; Yanping Liu; Lihong Liu
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.